Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: GNBT Generex

23 Nov 2015 11:03 PM <--

09 Jan 1999 02:11 PM

Return to GNBT Generex

Aerosol delivery of insulin for type 1&2 Diabetes is approved for FDA I & 2 trials. Comments on INHL board got me interested in this BB stock that has applied for NASDC listing. I will be in touch with my broker Monday to see what DD I can obtain. The company is located in Toronto (1 1/2 hrs away) so I should be able to obtain current info.
It looks interesting especially if a listing is coming! Obviously there is competition in this field & I do not know how good Generex's technology & science is. Comments would be appreciated!